Holen Sie sich die Stockscreener-App
2.26
2.26%
0.05
Handel nachbörslich:
2.26
Schlusskurs vom Vortag:
$2.21
Offen:
$2.18
24-Stunden-Volumen:
460.69K
Relative Volume:
1.56
Marktkapitalisierung:
$237.78M
Einnahmen:
$7.05M
Nettoeinkommen (Verlust:
$-30.43M
KGV:
-5.9662
EPS:
-0.3788
Netto-Cashflow:
$21.84M
1W Leistung:
+10.24%
1M Leistung:
-0.88%
6M Leistung:
-11.72%
1J Leistung:
+6.60%
1-Tages-Spanne:
$2.1601
$2.33
1-Wochen-Bereich:
$1.98
$2.33
52-Wochen-Spanne:
$1.07
$4.62
Proqr Therapeutics N V Stock (PRQR) Company Profile
Firmenname
Proqr Therapeutics N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRQR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.26 | 223.33M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-04-29 | Eingeleitet | Evercore ISI | Outperform |
| 2025-03-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-29 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | Herabstufung | Stifel | Buy → Hold |
| 2022-02-01 | Eingeleitet | Raymond James | Strong Buy |
| 2021-05-03 | Eingeleitet | Stifel | Buy |
| 2021-03-25 | Bestätigt | Citigroup | Buy |
| 2020-11-03 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-03-12 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-12-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-11-15 | Eingeleitet | Citigroup | Buy |
| 2018-09-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-09-26 | Bestätigt | JMP Securities | Mkt Outperform |
| 2016-06-20 | Eingeleitet | Chardan Capital Markets | Neutral |
| 2014-10-15 | Eingeleitet | Deutsche Bank | Buy |
| 2014-10-13 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Proqr Therapeutics N V Aktie (PRQR) Neueste Nachrichten
Custom strategy builders for tracking ProQR Therapeutics N.V.July 2025 Retail & Free AI Powered Buy and Sell Recommendations - Newser
Pattern Scan Adds ProQR Therapeutics N.V. to Watchlist2025 Winners & Losers & Accurate Entry/Exit Alerts - beatles.ru
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Real time breakdown of ProQR Therapeutics N.V. stock performanceQuarterly Growth Report & Capital Efficient Trading Techniques - Newser
Is now a turning point for ProQR Therapeutics N.V.Weekly Trade Recap & Precise Buy Zone Identification - Newser
Will ProQR Therapeutics N.V. see short term momentumOil Prices & Daily Momentum Trading Reports - Newser
How to track smart money flows in ProQR Therapeutics N.V.Long Setup & Fast Gain Swing Trade Alerts - Newser
Can ProQR Therapeutics N.V. hit a new high this monthJuly 2025 Decliners & Long-Term Growth Plans - Newser
Is ProQR Therapeutics N.V. stock a growth or value playPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
What data driven models say about ProQR Therapeutics N.V.’s futureJuly 2025 Opening Moves & Reliable Trade Execution Plans - Newser
How to build a dashboard for ProQR Therapeutics N.V. stockJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - Newser
How to recover losses in ProQR Therapeutics N.V. stockTrade Entry Report & Step-by-Step Swing Trade Plans - Newser
How high can ProQR Therapeutics N.V. stock goJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
Chart based analysis of ProQR Therapeutics N.V. trendsEarnings Risk Report & High Return Stock Watch Alerts - Newser
Volume spikes in ProQR Therapeutics N.V. stock – what they meanWeekly Trade Review & Daily Chart Pattern Signal Reports - Newser
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Candlestick Signal Suggests Reversal in ProQR Therapeutics N.V.July 2025 Drop Watch & Capital Efficiency Focused Strategies - sundaytimes.kr
Can ProQR Therapeutics N.V. recover in the next quarterWeekly Market Report & Weekly Top Gainers Alerts - Newser
Statistical indicators supporting ProQR Therapeutics N.V.’s strengthJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - Newser
Buy Signal for ProQR Therapeutics N.V. Stock Key Technical Indicators to WatchQuarterly Investment Review & Low Drawdown Momentum Ideas - Newser
Is ProQR Therapeutics N.V. stock entering bullish territoryEarnings Risk Summary & Risk Controlled Swing Trade Alerts - Newser
Published on: 2025-08-17 09:13:48 - metal.it
What to do if you’re stuck in ProQR Therapeutics N.V.Quarterly Investment Review & Safe Entry Momentum Tips - Newser
Live market analysis of ProQR Therapeutics N.V.Portfolio Profit Report & Technical Entry and Exit Alerts - Newser
Candlestick signals on ProQR Therapeutics N.V. stock todayWeekly Stock Recap & Accurate Buy Signal Alerts - Newser
How institutional ownership impacts ProQR Therapeutics N.V. stock2025 Earnings Surprises & Proven Capital Preservation Methods - Newser
What is the earnings history of ProQR Therapeutics N.V.Weekly Profit Analysis & Weekly Sector Rotation Insights - newsyoung.net
ProQR Therapeutics N.V. stock outlook for YEARPortfolio Growth Summary & Long-Term Growth Stock Strategies - Newser
Published on: 2025-08-16 03:26:16 - Newser
Can ProQR Therapeutics N.V. rally from current levels2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Using economic indicators to assess ProQR Therapeutics N.V. potentialPortfolio Performance Report & Safe Capital Growth Plans - Newser
Real time alert setup for ProQR Therapeutics N.V. performance2025 Price Momentum & Short-Term Trading Alerts - Newser
Will breakout in ProQR Therapeutics N.V. lead to full recoveryJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - Newser
ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces clinical hurdles - Investing.com Nigeria
Finanzdaten der Proqr Therapeutics N V-Aktie (PRQR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):